In chronic inflammatory diseases, such as deformable arthritis, diabetes mellitus type 1, and atherosclerosis, the expression of NKG2DLs is usually upregulated, and these ligands subsequently activate lymphocytes in the innate and adaptive immune systems through NKG2D receptors27,28. This evidence concerns the gene KLRK1 and atherosclerosis.